(Q41919452)

14 October 2017

Regression of Left Ventricular Hypertrophy with 1 Year of Antihypertensive Treatment in Type 1 Diabetic Patients with Early Nephropathy (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

left ventricular hypertrophy

3 December 2022

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

3 December 2022

author name string

M. J. Sampson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827393

3 December 2022

J. B. Chambers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827393

3 December 2022

D. C. Sprigings

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827393

3 December 2022

P. L. Drury

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827393

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827393

3 December 2022

publication date

1 February 1991

1 reference

full work available at URL

14 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01554.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01554.x/fullpdf

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

3 December 2022

1 reference

14 October 2017

8

1 reference

14 October 2017

2

1 reference

14 October 2017

106-110

1 reference

Treadmill stress tests as indicators of presence and severity of coronary artery disease

14 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01554.X

Regression of left ventricular hypertrophy during treatment with antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01554.X

Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01554.X

Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Intraventricular septal hypertrophy in type 1 diabetic patients with microalbuminuria or early proteinuria

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Echocardiographic-determined left ventricular wall characteristics in insulin-dependent diabetic patients

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Blood Pressure in a National Sample of U. S. Adults: Percentile Distribution by Age, Sex and Race

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Different patterns of left ventricular filling in arterial hypertension.

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Effect of enalapril on left ventricular mass and performance in essential hypertension.

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Left ventricular function in early primary hypertension. Functional consequences of cardiovascular structural changes

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Echocardiographic documentation of regression of left ventricular hypertrophy in patients treated for essential hypertension

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Assessment of left-ventricular mass and its response to antihypertensive treatment

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Adrenergic nervous system and left ventricular mass in primary hypertension.

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

The evolution of antihypertensive therapy: an overview of four decades of experience

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Impact of left ventricular hypertrophy on survival in end-stage renal disease

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Ventricular function and coronary hemodynamics in hypertensive heart disease

3 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension.

3 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

3 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01554.X

3 December 2022

Identifiers

1 reference

14 October 2017

1 reference